Conference item
Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Authors
Bibliographic Details
- Publisher:
- Wolters Kluwer Publisher's website
- Journal:
- International Journal of Gynecological Cancer Journal website
- Volume:
- 27
- Issue:
- S4
- Pages:
- 74
- Host title:
- International Journal of Gynecological Cancer
- Publication date:
- 2017-11-01
- Acceptance date:
- 2017-07-01
- DOI:
- EISSN:
-
1525-1438
- ISSN:
-
1048-891X
- Source identifiers:
-
824676
Item Description
- Keywords:
- Pubs id:
-
pubs:824676
- UUID:
-
uuid:42bf3788-ed9e-48c5-8db3-aa8e560cd854
- Local pid:
- pubs:824676
- Deposit date:
- 2018-07-16
Terms of use
- Copyright holder:
- International Gynecologic Cancer Society, European Society of Gynaecological Oncology
- Copyright date:
- 2017
- Notes:
- © 2017 by IGCS and ESGO. This is a conference paper presented at the 20th International Meeting of the European Society of Gynaecological Oncology, 4-7 November 2017, Vienna, Austria. This is the accepted manuscript version of the article. The final version is available online from Wolters Kluwer at: https://doi.org/10.1097/01.IGC.0000527296.86225.87
If you are the owner of this record, you can report an update to it here: Report update to this record